Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Toshner

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
BMJ Open|March 6, 2025
Assessing the impact of COmorbidities and Sociodemographic factors on Multiorgan Injury following COVID-19: rationale and protocol design of COSMIC, a UK multicentre observational study of COVID-negative controlsSimran Shergill, Mohamed Elshibly, Sandeep S Hothi, et al.
Thorax|September 15, 2017
The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertensionLaura C Price, Konstantinos Dimopoulos, Philip Marino, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 23, 2026
Long term effects of medical therapy pre- and post- pulmonary endarterectomy - insights from the UK CURATE registryPaula Appenzeller, Ashwin Reddy, Hakim Ghani, et al.
Nature Communications|January 6, 2024
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertensionAnna Ulrich, Yukyee Wu, Harmen Draisma, et al.
BMJ Open|October 6, 2020
How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysisNick G Cunniffe, Simon J Gunter, Michael Brown, et al.
Trials|August 2, 2024
Digital endpoints in clinical trials: emerging themes from a multi-stakeholder Knowledge Exchange eventMia S Tackney, Amber Steele, Joseph Newman, et al.
Circulation|April 8, 2016
Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National CohortJohn E Cannon, Li Su, David G Kiely, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 23, 2021
Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLTMarc de Perrot, Deepa Gopalan, David Jenkins, et al.
American Journal of Respiratory and Critical Care Medicine|August 11, 2025
Inflammation and Obesity Correlate in Pulmonary Hypertension but Associate with Diverging OutcomesEckart De Bie, Priscilla Correa-Jaque, Rowena Jones, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
BMJ Open|March 6, 2025
Assessing the impact of COmorbidities and Sociodemographic factors on Multiorgan Injury following COVID-19: rationale and protocol design of COSMIC, a UK multicentre observational study of COVID-negative controlsSimran Shergill, Mohamed Elshibly, Sandeep S Hothi, et al.
Thorax|September 15, 2017
The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertensionLaura C Price, Konstantinos Dimopoulos, Philip Marino, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 23, 2026
Long term effects of medical therapy pre- and post- pulmonary endarterectomy - insights from the UK CURATE registryPaula Appenzeller, Ashwin Reddy, Hakim Ghani, et al.
Nature Communications|January 6, 2024
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertensionAnna Ulrich, Yukyee Wu, Harmen Draisma, et al.
BMJ Open|October 6, 2020
How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysisNick G Cunniffe, Simon J Gunter, Michael Brown, et al.
Trials|August 2, 2024
Digital endpoints in clinical trials: emerging themes from a multi-stakeholder Knowledge Exchange eventMia S Tackney, Amber Steele, Joseph Newman, et al.
Circulation|April 8, 2016
Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National CohortJohn E Cannon, Li Su, David G Kiely, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 23, 2021
Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLTMarc de Perrot, Deepa Gopalan, David Jenkins, et al.
American Journal of Respiratory and Critical Care Medicine|August 11, 2025
Inflammation and Obesity Correlate in Pulmonary Hypertension but Associate with Diverging OutcomesEckart De Bie, Priscilla Correa-Jaque, Rowena Jones, et al.
Pageof 10